US Patent 7576176 None
Patent 7576176 was granted and assigned to Novartis on August, 2009 by the United States Patent and Trademark Office.
All edits
Edits on 17 Sep, 2023
Golden AI
Edits made to:
Infobox (+14 properties)
Infobox
Patent Inventor Names
Cesira Galeotti0
Claire Fraser0
Erin Hickey0
Giulio Ratti0
Guido Grandi0
Herve Tettelin0
J. Craig Venter0
Jeremy Petersen0
Maria Scarselli0
Mariagrazia Pizza0
Marirosa Mora0
Rino Rappuoli0
Vega Masignani0
Vincenzo Scarlato0
Edits on 15 Sep, 2023
Golden AI
Edits made to:
Article (+236 characters)
Article
Patent abstract
The invention provides proteins from Neisseria meningitidis, including the amino acid sequences and the corresponding nucleotide sequences. The proteins are predicted to be useful antigens for vaccines and/or diagnostics.
Edits on 21 Jun, 2023
Golden AI
Edits on 25 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07576176 None US Patent 7576176 None
Infobox
Patent Number
075761760
Patent Number
75761760
Edits on 21 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 25 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
075761760
Date of Patent
August 18, 2009
0Patent Application Number
096745460
Date Filed
April 30, 1999
0Official Website
Patent Primary Examiner
Edits on 18 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 2 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07576176 None
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07576176
Date of patent
August 18, 2009
Patent application number
09674546
Date Filed
April 30, 1999
Patent primary examiner
Find more entities like US Patent 7576176 None
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
